Senators question FDA policy on advisory panels

A group of senators asked the Government Accountability Office to review the FDA's policy of allowing medical experts with financial ties to drug and medical-device manufacturers to serve on FDA advisory panels. The practice of granting waivers for such experts appears to have "undermined the public's faith in the objectivity and fairness of FDA's advisory committees," the senators said.

View Full Article in: (Hackensack, N.J.) (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Fort Worth, TX
Senior Scientist - Cell Engineering Group
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC